---
title: "CRT 2024: US DCB approval provides “important treatment option” for in-stent restenosis"
date: "2024-03-21T14:16:08.000Z"
publishedDate: "21 mars 2024"
summary: "The first US Food and Drug Administration (FDA) approval of a drug-coated balloon (DCB) for the treatment of coronary in-stent restenosis will ensure that the therapy becomes “an important new treatment option for patients with coronary stenosis in the USA”, an investigator in the trial that supported the approval has said. Robert W Yeh (Beth [&#8230;] The post CRT 2024: US DCB approval provides “important treatment option” for in-stent restenosis appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/dcb-approval-crt-2024/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-03-21-crt-2024-us-dcb-approval-provides-important-treatment-option-for-in-stent-restenosis"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2021/06/Robert-W-Yeh-300x292-1.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/dcb-approval-crt-2024/"
---

![CRT 2024: US DCB approval provides “important treatment option” for in-stent restenosis](https://cardiovascularnews.com/wp-content/uploads/sites/14/2021/06/Robert-W-Yeh-300x292-1.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/dcb-approval-crt-2024/*

## L’essentiel

The first US Food and Drug Administration (FDA) approval of a drug-coated balloon (DCB) for the treatment of coronary in-stent restenosis will ensure that the therapy becomes “an important new treatment option for patients with coronary stenosis in the USA”, an investigator in the trial that supported the approval has said. Robert W Yeh (Beth [&#8230;] The post CRT 2024: US DCB approval provides “important treatment option” for in-stent restenosis appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/dcb-approval-crt-2024/
